Thank you, Mr. Chair.
I want to thank both of you for being here with us this afternoon. I want to extend a very warm welcome to Mr. Robinson.
It's as though you made it to the National Hockey League while I was still in the minor leagues doing my homework, when you were a player.
In listening to you, I drew a parallel, and I would like you to tell me if it makes sense in terms of the study we are doing currently on countries of focus.
You are fighting a very long-term battle against three diseases in particular: AIDS, malaria and tuberculosis. At the Global Fund to Fight AIDS, Tuberculosis and Malaria, you must nevertheless have the necessary flexibility to respond to urgent requests such as the recent Ebola outbreak, or Zika; we do not yet know everything about that one, such as how widespread or serious it could become.
With the budget you have at your disposal, how do you balance this long-term permanent work that produces results, and the leeway you need to react to epidemics that occur periodically?